The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Silybin and silymarin - new effects and applications
Open accessAbstract
This article aims to review critically literature published mainly within this millennium on the new and emerging applications of silymarin, the polyphenolic fraction from the seeds of Silybum marianum and its main component silybin. Silymarin and silybin used so far mostly as hepatoprotectants were shown to have other interesting activities as e.g., anticancer and canceroprotective. These activities were demonstrated in a large variety of illnesses of different organs as e.g., prostate, lungs, CNS, kidneys, pancreas and others. Besides the cytoprotective activity of silybin mediated by its antioxidative and radical-scavenging properties also new activities based on the specific receptor interaction were discovered--e.g., inhibition and modulation of drug transporters, P-glycoproteins, estrogenic receptors, nuclear receptors and some others. New derivatives of silybin open new ways to its therapeutic applications. Pharmacology dealing with optically pure silybin diastereomers may suggest new mechanisms of its action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
International Journal of Molecular Medicine
(2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm · Cited by 2,246
The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines
Marty, A. T. (1999) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.281.19.1852 · Cited by 846
Milk Thistle (Silybum marianum) for the Therapy of Liver Disease
Flora, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00082-8 · Cited by 746
The Use of Silymarin in the Treatment of Liver Diseases
Saller, R., Meier, R., & Brignoli, R. (2001) · Drugs · doi:10.2165/00003495-200161140-00003 · Cited by 718
Mueller, S. O. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh147 · Cited by 547
Role of chemopreventive agents in cancer therapy
Dorai, T., & Aggarwal, B. B. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.07.013 · Cited by 529
Natural phenolics in the prevention of UV-induced skin damage. A review
Svobodová, A., Psotová, J., & Walterová, D. (2003) · Biomedical Papers · doi:10.5507/bp.2003.019 · Cited by 455
Self-citationFraschini, F., Demartini, G., & Esposti, D. (2002) · Clinical Drug Investigation · doi:10.2165/00044011-200222010-00007 · Cited by 380
Herbal Modulation of P‐Glycoprotein
Zhou, S., Lim, L. Y., & Chowbay, B. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120028427 · Cited by 375
Cited by
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
Federico, A., Dallio, M., & Loguercio, C. (2017) · Molecules · doi:10.3390/molecules22020191 · Cited by 492
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Gillessen, A., & Schmidt, H. H.-J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01251-y · Cited by 490
Bijak, M. (2017) · Molecules · doi:10.3390/molecules22111942 · Cited by 414
New insights into antioxidant strategies against paraquat toxicity
Blanco-Ayala, T., Andérica-Romero, A. C., & Pedraza-Chaverri, J. (2014) · Free Radical Research · doi:10.3109/10715762.2014.899694 · Cited by 256
Cicero, A. F. G., & Colletti, A. (2016) · Phytomedicine · doi:10.1016/j.phymed.2015.10.011 · Cited by 70
Simancas-Racines, D., Annunziata, G., Verde, L., Fascì-Spurio, F., Reytor-González, C., Muscogiuri, G., Frias-Toral, E., & Barrea, L. (2025) · Current Obesity Reports · doi:10.1007/s13679-024-00597-6 · Cited by 61
Metadata
- Authors
- Křen, V., & Walterová, D.
- Venue
- Biomedical Papers
- Publisher
- Palacky University Olomouc
- Published
- 2005-07-01
- Volume
- 149
- Issue
- 1
- Pages
- 29-41
- ISSN
- 1213-8118 (ISSN-L)
- 1804-7521
- OpenAlex
- W2168162647
- Cited by
- 446
- References
- 93
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.